1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Veterinary Eye Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Veterinary Eye Care Market Revenue and Volume Forecast, by Animal
8.1.1. Canine
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Feline
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Equine
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Bovine
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast
9.1. Veterinary Eye Care Market Revenue and Volume Forecast, by Product
9.1.1. Devices & Instruments
9.1.1.1. Market Revenue and Volume Forecast
10.1. Veterinary Eye Care Market Revenue and Volume Forecast, by Indication
10.1.1. Eyelid Abnormalities
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Cataract
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Glaucoma
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Retinal Complications
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Uveitis
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Conjunctivitis
10.1.6.1. Market Revenue and Volume Forecast
10.1.7. Corneal Complications
10.1.7.1. Market Revenue and Volume Forecast
10.1.8. Other Indications
10.1.8.1. Market Revenue and Volume Forecast
11.1. Veterinary Eye Care Market Revenue and Volume Forecast, by Distribution Channel
11.1.1. Veterinary Hospitals & Clinics
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Specialty Stores
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. E-Commerce
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Other Distribution Channels
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Animal
12.1.2. Market Revenue and Volume Forecast, by Product
12.1.3. Market Revenue and Volume Forecast, by Indication
12.1.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Animal
12.1.5.2. Market Revenue and Volume Forecast, by Product
12.1.5.3. Market Revenue and Volume Forecast, by Indication
12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Animal
12.1.6.2. Market Revenue and Volume Forecast, by Product
12.1.6.3. Market Revenue and Volume Forecast, by Indication
12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Animal
12.2.2. Market Revenue and Volume Forecast, by Product
12.2.3. Market Revenue and Volume Forecast, by Indication
12.2.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Animal
12.2.5.2. Market Revenue and Volume Forecast, by Product
12.2.5.3. Market Revenue and Volume Forecast, by Indication
12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Animal
12.2.6.2. Market Revenue and Volume Forecast, by Product
12.2.6.3. Market Revenue and Volume Forecast, by Indication
12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Animal
12.2.7.2. Market Revenue and Volume Forecast, by Product
12.2.7.3. Market Revenue and Volume Forecast, by Indication
12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Animal
12.2.8.2. Market Revenue and Volume Forecast, by Product
12.2.8.3. Market Revenue and Volume Forecast, by Indication
12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Animal
12.3.2. Market Revenue and Volume Forecast, by Product
12.3.3. Market Revenue and Volume Forecast, by Indication
12.3.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Animal
12.3.5.2. Market Revenue and Volume Forecast, by Product
12.3.5.3. Market Revenue and Volume Forecast, by Indication
12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Animal
12.3.6.2. Market Revenue and Volume Forecast, by Product
12.3.6.3. Market Revenue and Volume Forecast, by Indication
12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Animal
12.3.7.2. Market Revenue and Volume Forecast, by Product
12.3.7.3. Market Revenue and Volume Forecast, by Indication
12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Animal
12.3.8.2. Market Revenue and Volume Forecast, by Product
12.3.8.3. Market Revenue and Volume Forecast, by Indication
12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Animal
12.4.2. Market Revenue and Volume Forecast, by Product
12.4.3. Market Revenue and Volume Forecast, by Indication
12.4.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Animal
12.4.5.2. Market Revenue and Volume Forecast, by Product
12.4.5.3. Market Revenue and Volume Forecast, by Indication
12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Animal
12.4.6.2. Market Revenue and Volume Forecast, by Product
12.4.6.3. Market Revenue and Volume Forecast, by Indication
12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Animal
12.4.7.2. Market Revenue and Volume Forecast, by Product
12.4.7.3. Market Revenue and Volume Forecast, by Indication
12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Animal
12.4.8.2. Market Revenue and Volume Forecast, by Product
12.4.8.3. Market Revenue and Volume Forecast, by Indication
12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Animal
12.5.2. Market Revenue and Volume Forecast, by Product
12.5.3. Market Revenue and Volume Forecast, by Indication
12.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Animal
12.5.5.2. Market Revenue and Volume Forecast, by Product
12.5.5.3. Market Revenue and Volume Forecast, by Indication
12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Animal
12.5.6.2. Market Revenue and Volume Forecast, by Product
12.5.6.3. Market Revenue and Volume Forecast, by Indication
12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel
13.1. Merck & Co., Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerAnimalance
13.1.4. Recent Initiatives
13.2. An-Vision GmbH
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerAnimalance
13.2.4. Recent Initiatives
13.3. Jorgensen Laboratories
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerAnimalance
13.3.4. Recent Initiatives
13.4. LKC Technologies Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerAnimalance
13.4.4. Recent Initiatives
13.5. Accutome Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerAnimalance
13.5.4. Recent Initiatives
13.6. Dechra Pharmaceuticals
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerAnimalance
13.6.4. Recent Initiatives
13.7. Bausch & Lomb Incorporated
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerAnimalance
13.7.4. Recent Initiatives
13.8. Zoetis Services LLC.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerAnimalance
13.8.4. Recent Initiatives
13.9. Ceva Santé Animale
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerAnimalance
13.9.4. Recent Initiatives
13.10. Sandoz
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerAnimalance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client